Playlist


World leaders congratulate the National Leader of the Turkmen People, Chairman of the Halk Maslahaty on his birthday
29 Jun. 06:42The Chairman of the Halk Maslahaty of Turkmenistan and National Leader of the Turkmen People, Gurbanguly Berdimuhamedov, received numerous congratulatory letters and official telegrams from foreign heads of state, government leaders, and prominent international figures on the occasion of his birthday. As reported by the official "Turkmenistan" newspaper, the diplomatic correspondence highly praises the National Leader's extensive statecraft and his significant contributions to strengthening bilateral ties and international cooperation.
Sincere congratulations and best wishes for robust health and longevity were extended by the President of the Republic of Uzbekistan Shavkat Mirziyoyev, the President of the Republic of Azerbaijan Ilham Aliyev, the President of the Republic of Tajikistan Emomali Rahmon, the President of the Republic of Korea Lee Jae-myung, the President of the Republic of Belarus Aleksandr Lukashenko, and the President of Ukraine Volodymyr Zelenskyy. The world leaders emphasized their continued commitment to advancing strategic partnerships with Turkmenistan.
Furthermore, formal greetings were conveyed by the Prime Minister of the Republic of Armenia Nikol Pashinyan, the Prime Minister of the Russian Federation Mikhail Mishustin, the Deputy Chairman of the Security Council of the Russian Federation Dmitry Medvedev, and the Chairwoman of the Federation Council of the Federal Assembly of the Russian Federation Valentina Matvienko. Additional warm wishes were extended by Sheikh Faisal bin Nasser bin Hamad Al Thani, a member of the ruling family of the State of Qatar, Neda Berger, Head of the Turkmen-Austrian Society, and Dmitry Kobitsky, Secretary General of the Council of the CIS Interparliamentary Assembly, highlighting the ongoing importance of humanitarian and parliamentary diplomacy.
Also read


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.